Zydus Cadila files drug application to treat obesity
14th Nov 2006, 11:06 GMT
Mumbai, Nov 14: Pharma major Cadila Healthcare Ltd today said it has filed Investigational New Drug (IND) application with Drug Controller General of India for a new drug to treat obesity and related disorders.
Zydus Cadila files drug application to treat obesity related news:
- Neurogen commences human testing of obesity drug — Pharmaceutical Business Review Latest News
- Neurogen Announces Phase I Clinical Trial For Proprietary Obesity Drug — Health News from Medical News Today
- Neurogen's obesity drug in phase 1 trial — United Press International - Health Business
- Treat HIV-Positive Addicts To Slow AIDS In Russia, Stanford Study Says — Health News from Medical News Today
- Dendreon completes FDA filing for prostate-cancer drug — The Seattle Times: Horse racing
- Diabetes drug stalls heart disease — United Press International - Health Business
- Anti-cancer drug shows early promise in pulmonary hypertension — EurekAlert! - Breaking News
- Alexion gets fast-track FDA review for drug Soliris — bizjournals.com Health Care:Pharmaceuticals headlines
- MedaSorb Technologies Corp Files New Patent Application — StratWire - Business of Healthcare NewsFeed
- HGS reports positive Lupus drug test results — StratWire - Business of Healthcare NewsFeed
Latest news from NewKerala Business India News:
- NTPC to manufacture LED lamps
- GE India targets $8 bn revenue by 2010
- Sensex, Nifty soars to new peaks on robust economic growth
- Hindustan Tin gets shareholders nod for Maharashtra unit sell off
- 57 pc telcos fail to meet quality of service criteria
- RINL plans to set up SEZ in Andhra Pradesh
- Ashok Leyland allots 23 lakh shares upon conversion of notes
- Novo Nordisk to conduct programme on diabetes management
- Zee Sports, Ten Sports merger not ruled out
- iGate wins three-year deal from Radian